Approved comparison material connected to this topic.
9 total recordsSource comparisons are presented without a generated winner.
Dosage "Administered 0.25mg MT-2" 250 mcg reconstituted from 10mg vial at 1mg/mL, confirmed via peptide mass calculation Concentration errors are the #1 cause of underdosing or overdosing in peptide research T…
Recording that you administered 250 mcg of MT-2 is dosage tracking. Documenting whether that 250 mcg produced measurably different pigmentation than 200 mcg is dose-response mapping, and the latter is what res…
Photoprotection (Levine et al., 1998) 0.025 mg/kg SC 3×/week × 4 weeks Minimal erythema dose (MED) increase 2–3× MED increase; 5–6 Pantone units darker Nausea (60–70%), flushing (40%), spontaneous erections (m…
This is the section that keeps the rest honest. There is no study in which PT-141 and Melanotan II were administered to comparable subjects and measured against each other — not in humans, and not even in the …
Several structural limitations constrain everything above, and honest readers should keep them in view: No head-to-head data. Comparing the two requires stitching together studies that differ in population, en…
Melanotan-1 vs Melanotan-2 — The Research Comparison Melanotan-1 and Melanotan-2 activate melanocortin receptors differently, producing distinct tanning, appetite, and cardiovascular effects for research Resea…
The table below summarises the structural, pharmacological, and regulatory differences that define the Melanotan-1 vs Melanotan-2 comparison for research applications. Structure Linear 13-amino-acid peptide (N…
Research published in the Journal of Medicinal Chemistry identified a single amino acid substitution that transforms melanocortin receptor selectivity. And with it, the entire safety and efficacy profile of sy…
Here's the honest answer: the Melanotan-1 vs Melanotan-2 question is not about choosing the 'better' peptide. It's about matching receptor selectivity to experimental endpoints. Melanotan-1 is a precision tool…